InvestorsHub Logo
Followers 7
Posts 530
Boards Moderated 0
Alias Born 01/21/2021

Re: JoeLahr post# 95521

Wednesday, 06/30/2021 9:48:31 AM

Wednesday, June 30, 2021 9:48:31 AM

Post# of 113915
From NY times

“In a trial of hospitalized patients, however, molnupiravir seemed to have no effect on the disease. In April, the companies announced they were scrapping the trial.

“I see that, and I’m like, ‘Yeah, no duh,’” said Dr. Tim Sheahan, a virologist at the University of North Carolina. “It’s not surprising to me that those kinds of medications would not make a dramatic improvement in someone’s outcome when they’ve been sick for several days.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News